Differential expression of TRAIL and its receptors relative to calcification in AAA

Biochemical and Biophysical Research Communications

Volumn 358, Issue 1, 2007, Pages 18-23

  Liu, Xun ^a   Winrow, Vivienne R ^a   Horrocks, Michael ^a,b   Stevens, Cliff R ^a  

^a University of Bath   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Abdominal aortic aneurysm; Apoptosis; Osteoprotegerin; TNF related apoptosis inducing ligand (TRAIL); TRAIL receptors; Vascular calcification

Indexed keywords

MESSENGER RNA; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; APOPTOSIS; ARTERY CALCIFICATION; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOTTING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; CALCINOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34248143572     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.03.209     Document Type: Article

References (27)

1. Pleumeekers H.J., Hoes A.W., van der D.E., van U.H., and Grobbee D.E. Epidemiology of abdominal aortic aneurysms. Eur. J. Vasc. Surg. 8 (1994) 119-128
2. T. Wilmink, The nature history of aneurysm, in: Anonymous, Vascular Surgical Society of Great Britain, Ireland, 2004.
3. Thompson R.W., Liao S., and Curci J.A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coron. Artery Dis. 8 (1997) 623-631
4. Jorgensen L., Singh K., Berntsen G.K., and Jacobsen B.K. A population-based study of the prevalence of abdominal aortic aneurysms in relation to bone mineral density: the Tromso study. Am. J. Epidemiol. 159 (2004) 945-949
5. Patel M.I., Hardman D.T., Fisher C.M., and Appleberg M. Current views on the pathogenesis of abdominal aortic aneurysms. J. Am. Coll. Surg. 181 (1995) 371-382
6. Tintut Y., and Demer L. Role of osteoprotegerin and its ligands and competing receptors in atherosclerotic calcification. J. Investig. Med. 54 (2006) 395-401
7. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., and Smith C.A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
8. Schneider P., and Tschopp J. Apoptosis induced by death receptors. Pharm. Acta Helv. 74 (2000) 281-286
9. LeBlanc H.N., and Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ. 10 (2003) 66-75
10. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ. Res. 95 (2004) 1046-1057
11. Miyashita T., Kawakami A., Nakashima T., Yamasaki S., Tamai M., Tanaka F., Kamachi M., Ida H., Migita K., Origuchi T., Nakao K., and Eguchi K. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. Clin. Exp. Immunol. 137 (2004) 430-436
12. Blair J.M., Zhou H., Seibel M.J., and Dunstan C.R. Mechanisms of disease: roles of OPG, RANKL and RANK in the pathophysiology of skeletal metastasis. Nat. Clin. Pract. Oncol. 3 (2006) 41-49
13. Moran C.S., McCann M., Karan M., Norman P., Ketheesan N., and Golledge J. Association of osteoprotegerin with human abdominal aortic aneurysm progression. Circulation 111 (2005) 3119-3125
14. Barres B.A., Hart I.K., Coles H.S., Burne J.F., Voyvodic J.T., Richardson W.D., and Raff M.C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70 (1992) 31-46
15. Arends M.J., McGregor A.H., and Wyllie A.H. Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am. J. Pathol. 144 (1994) 1045-1057
16. Manolagas S.C. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21 (2000) 115-137
17. Bostrom K. Insights into the mechanism of vascular calcification. Am. J. Cardiol. 88 (2001) 20E-22E
18. Shanahan C.M., Proudfoot D., Tyson K.L., Cary N.R., Edmonds M., and Weissberg P.L. Expression of mineralisation-regulating proteins in association with human vascular calcification. Z. Kardiol. 89 Suppl. 2 (2000) 63-68
19. Aubin J.E., and Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos. Int. 11 (2000) 905-913
20. Schinke T., and Karsenty G. Vascular calcification-a passive process in need of inhibitors. Nephrol. Dial. Transplant. 15 (2000) 1272-1274
21. Pennisi P., Signorelli S.S., Riccobene S., Celotta G., Di P.L., La M.T., and Fiore C.E. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos. Int. 15 (2004) 389-395
22. Sattler A.M., Schoppet M., Schaefer J.R., and Hofbauer L.C. Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. Calcif. Tissue Int. 74 (2004) 103-106
23. Schulz E., Arfai K., Liu X., Sayre J., and Gilsanz V. Aortic calcification and the risk of osteoporosis and fractures. J. Clin. Endocrinol. Metab 89 (2004) 4246-4253
24. Taylor T.W., and Yamaguchi T. Three-dimensional simulation of blood flow in an abdominal aortic aneurysm---steady and unsteady flow cases. J. Biomech. Eng. 116 (1994) 89-97
25. Scott J.H. The mechanical basis of bone formation. J. Bone Joint Surg. Br. 39-B (1957) 134-144
26. Dhore C.R., Cleutjens J.P., Lutgens E., Cleutjens K.B., Geusens P.P., Kitslaar P.J., Tordoir J.H., Spronk H.M., Vermeer C., and Daemen M.J. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1998-2003
27. The regulation of osteoprotegerin by mechanical stimulation, The University of Taiwan, 2005 www.clinicaltrials.gov.